Table 4

Univariate and multivariate analysis for risk factors predicting thrombotic events in follow-up (events, n = 27)

Univariate analysis
Multivariate analysis
HR95% CIPHR95% CIP
Time elapsed from diagnosis (> 5 vs < 5 mo) 0.84 0.39-1.79 .65 0.85 0.39-1.85 .68 
Sex (male vs female) 0.89 0.39-1.98 .77 0.89 0.39-2.02 .78 
Age > 60 y 2.37 0.97-5.78 .06 2.99 1.19-7.51 .02 
Previous thrombosis 3.23 1.45-7.18 .004 3.63 1.61-8.16 .002 
JAK2V617F 1.17 0.51-2.71 .71 0.96 0.34-2.46 .94 
Response to HU       
    CR 1 (ref)      
    PR 1.38 0.62-3.10 .43 5.08 0.65-16 .12 
    No response 1.00 0.35-2.45 .87 4.47 0.45-25 .20 
PLT,* ×109/L       
    Less than 400 1 (ref)   1 (ref)   
    More than 400 1.04 0.39-2.74 .95 0.24 0.04-1.58 .14 
WBC, ×109/L       
    Less than 10 1 (ref)   1 (ref)   
    More than 10 2.85 1.27-6.39 .01 2.86 1.23-6.66 .015 
Univariate analysis
Multivariate analysis
HR95% CIPHR95% CIP
Time elapsed from diagnosis (> 5 vs < 5 mo) 0.84 0.39-1.79 .65 0.85 0.39-1.85 .68 
Sex (male vs female) 0.89 0.39-1.98 .77 0.89 0.39-2.02 .78 
Age > 60 y 2.37 0.97-5.78 .06 2.99 1.19-7.51 .02 
Previous thrombosis 3.23 1.45-7.18 .004 3.63 1.61-8.16 .002 
JAK2V617F 1.17 0.51-2.71 .71 0.96 0.34-2.46 .94 
Response to HU       
    CR 1 (ref)      
    PR 1.38 0.62-3.10 .43 5.08 0.65-16 .12 
    No response 1.00 0.35-2.45 .87 4.47 0.45-25 .20 
PLT,* ×109/L       
    Less than 400 1 (ref)   1 (ref)   
    More than 400 1.04 0.39-2.74 .95 0.24 0.04-1.58 .14 
WBC, ×109/L       
    Less than 10 1 (ref)   1 (ref)   
    More than 10 2.85 1.27-6.39 .01 2.86 1.23-6.66 .015 

Variables at 12 months of HU treatment. PLT indicates platelets.

*

For PLT > 600 × 109/L; hazard ratio = 1.05; P = .91.

Close Modal

or Create an Account

Close Modal
Close Modal